chemotherapeutic


Also found in: Dictionary, Thesaurus, Medical.

chemotherapeutic

[‚kē·mō‚ther·ə‚pyüd·ik]
(pharmacology)
Any agent used for chemotherapy.
References in periodicals archive ?
Johnson explained that happens as flavonoids can act as antioxidants; one of the ways that chemotherapeutic drugs kill cells is based on their pro-oxidant activity, meaning that flavonoids and chemotherapeutic drugs may compete with each other when they're introduced at the same time.
CONCLUSIONS: miR-205 and miR-31 play an important role in apoptosis induced by chemotherapeutic drugs and can be a useful strategy to treat the prostate cancer at an advanced stage.
8,9) Additionally, in contrast to local chemotherapeutics, systemic antibiotic usage presents the risk of producing antibiotic resistant bacterial strains.
The registry is aimed at clarifying risk on the basis of the types and dosages of chemotherapeutic drugs used, the age and genotype of the fetus, and other factors.
The patient was placed on the standard chemotherapeutic regimen for remission induction of AML.
The patented technology affords pinpoint accuracy in delivering a chemotherapeutic drug to targeted tumor cells, reducing drug-related toxicity without sacrificing therapeutic impact.
The biggest advantage of this potential strategy is that no toxic chemotherapeutic drug is needed to achieve the same cancer killing effect used with a combination of Chk1 inhibitors and chemotherapeutic drugs.
Since that 1983 report, investigators have recognized that hydroxyurea's curative powers extend to minichromosomes that contain genes countering other chemotherapeutic drugs or genes, such as c-myc, that promote the growth of cancer cells.
He notes, "Knowing the mechanism of how hypoxia leads to drug resistance can only help people develop better chemotherapeutic agents.
for the intrathecal administration of chemotherapeutic treatment
AmpliMed's multi-center studies using a combination of Amplimexon[R] and common chemotherapeutic agents in Stage IV metastatic melanoma (Phase II) and advanced pancreatic adenocarcinoma (Phase Ib) are scheduled to be completed early next year.
Results of tests in which a variety of drug resistant tumor cell lines were treated with CT-2584 in cytotoxicity assays show that CT-2584 killed tumor cells by a novel mechanism of action: the chemotherapeutic agent alters production of the intracellular second messenger, phosphatidic acid (PA), which is involved in a variety of agonist stimulated cell growth and activation responses.